Beijing Genomics Institute Shenzhen, Saudi Biosciences, CLC Bio, 23andMe, Ancestry.com, Broad Institute, Duke University, Eurofins, Operon, NIH, Zygem, Commonwealth Biotechnologies, 5 Prime, International Rice Research Institute, eGenomics, Invitrogen | GenomeWeb
BGI Shenzhen, Saudi Biosciences, CLC Bio Sequence Arab’s Genome
 
Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC Bio said this week that they have used Illumina’s Genome Analyzer to sequence and analyze the genome of an Arab individual, which they claim to be the first such genome ever sequenced.
 
The study is part of a larger project to sequence 100 Arab human genomes at high resolution by the end of 2010, with the aim to map unique genetic variations of the Arab population.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.